United States Bio-based Molecule Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Bio-based Molecule Market reached US$ 1,336.72 million in 2023 and is expected to reach US$ 2,437.83 million by 2031 growing with a CAGR of 7.8% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "Bio-Based Molecule Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/bio-based-molecule-market?sg

Key Players: Arkema, GEA Group Aktiengesellschaft, IEA Bioenergy, DE Smet Engineers & Contractors, AVA Biochem AG, Borregaard AS, Jiangmen Xinshuo New Materials Co., Ltd, Northern Technologies International Corporation (NTIC), Gevo and Covestro AG.

United States - Industry Developments:

✅ Mitsubishi Chemical Group Launches Biodegradable Plastics
In September 2025, Mitsubishi Chemical Group introduced biodegradable plastics derived from non-food biomass for packaging and consumer goods.

✅ Braskem Unveils Bio-Based Product Innovations at K 2025
On October 9, 2025, Braskem introduced new applications of Machine Direction-Oriented (MDO) technology using bio-based polyethylene derived from sugarcane.

Japan - Industry Developments:

✅ Takeda and Nabla Bio Expand AI Drug Design Partnership
On October 14, 2025, U.S. biotech firm Nabla Bio announced a second major research partnership with Japan's Takeda Pharmaceutical, focusing on AI-driven drug design.

✅ Japan's Bio-Economy Push at BioJapan 2024 Extends into 2025
As of October 2, 2025, Japan's strategic focus on regenerative medicine and gene therapy continues to gain momentum, setting high expectations for 2025.

South Korea - Industry Developments:

✅ Celltrion in Talks to Buy Eli Lilly Plant in US for $504 Million
On August 8, 2025, Celltrion Inc. entered negotiations with Eli Lilly and Company to acquire a U.S. manufacturing plant for $504 million.

✅ Korean Biotech Sector Kicks Off 2025 with Multi-Billion-Dollar Deals
As of March 19, 2025, South Korea's biotech firms secured nearly $2.3 billion in licensing deals in the first quarter.

Europe - Industry Developments:

✅ BIO-Europe 2025 to Spotlight Biopharma Innovation and Deal-Making in Vienna
On September 24, 2025, BIO-Europe 2025 in Vienna announced plans to gather global biopharma leaders to explore investment, manufacturing, and rare disease innovation.

✅ Unlocking Europe's Bio-Based Future: New CBE JU Publication Now Available
On July 22, 2025, the CBE JU highlighted Europe's growing bioeconomy, with over €1.3 billion invested and more than 260 new bio-based materials and ingredients developed.

Growth Forecast Projected:

The Global Bio-Based Molecule Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Bio-Based Molecule Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bio-based-molecule-market?sg

Key Segments:

By Product Type (Bio-Based Platform Chemicals, Carboxylic Acids, Alcohols, Esters, Others)

By Raw Material (Plant-based Feedstocks, Agricultural, Waste Forestry Materials)

By Application (Food and Beverage, Personal Care, Pharmaceuticals, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Bio-Based Molecule producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Bio-Based Molecule revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bio-based-molecule-market?sg

FAQ's

Q1: What is the current size of the Bio-Based Molecule Market?

A: The Bio-Based Molecule Market stood at US$ 1,336.72 million in 2023 and is set to experience remarkable growth, reaching US$ 2,437.83 million by 2031

Q2: How fast is the Bio-Based Molecule Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 7.8% from 2024-2031

Q3: Which regions are dominating the Bio-Based Molecule Market and which are fastest-growing?

A: North America accounted for approximately 35.5% of the global bio-based molecule market share.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/bio-based-molecule-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.